Abstract
Mitochondrial replacement therapy (MRT), also known as mitochondrial donation (MD), is promoted as an option to prevent transmission of mitochondrial disorders to offspring. Since its first reported use in humans, MRT has raised numerous ethical and medical concerns. This article will explore the technology behind MRT and arguments in favor of and opposing it, concluding that a response through the lens of Scripture promotes flourishing of individuals and families affected by mitochondrial disorders without sacrificing others in the process.
Keywords: mitochondrial disorders, mitochondrial replacement therapy, DNA, embryo, germ line, disability, parenthood
This content is restricted to active online subscriptions.
To read the full text or download the PDF please log in or subscribe today.
Cite as: Cynthia Nash, “Mitochondrial Replacement Therapy, the Embryo, and Community,” Ethics & Medicine 37, no. 2-3 (2021): 121–133.
About the Author
Cynthia Nash
Cynthia I. Nash, MD, MA, is a Clinical Assistant Professor with Via Christi Family Medicine Residency and the Department of Family and Community Medicine at the University of Kansas Medical School, Wichita, Kansas. She completed her medical degree from Eastern Virginia Medical School and her MA in Bioethics from Trinity International University. The views expressed are her own and do not necessarily reflect the positions of organizations with which she is affiliated.